| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/01/2004 | US20040062772 Attenuated live neospora vaccine |
| 04/01/2004 | US20040062762 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 04/01/2004 | US20040062758 Immunostimulant; mixture of lactobacillus, propionibacterium, bifidobacterium |
| 04/01/2004 | US20040062757 Method of testing gastrointestinal diseases associated with species of genus clostridium |
| 04/01/2004 | US20040062755 Liquid culture product; tissue engineering |
| 04/01/2004 | US20040062752 Genetic engineered polynucleotide; antihemophilic factor; in situ administering to liver |
| 04/01/2004 | CA2499643A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | CA2499625A1 Methods of increasing platelet and hematopoietic stem cell production |
| 04/01/2004 | CA2497554A1 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 03/31/2004 | EP1402898A1 Use of glycoprotein for the treatment and re-epithelialisation of wounds |
| 03/31/2004 | EP1402786A1 Ximenynic acid |
| 03/31/2004 | EP1402034A2 Identification of ses-1 and the uses of the same |
| 03/31/2004 | EP1402005A1 A method of purification of cells |
| 03/31/2004 | EP1402004A2 Remodeling of somatic nuclei upon addition of pluripotent cell extracts |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1401857A2 Purification of human serum albumin |
| 03/31/2004 | EP1401495A2 T cell induced tissue repair and regeneration |
| 03/31/2004 | EP1401480A2 Use of endostatin in the treatment of ocular neovascularization |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401468A2 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 03/31/2004 | EP1401457A1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
| 03/31/2004 | EP1401456A1 Method fron determining the efficacy of reverse cholesterol transport enhancing agents |
| 03/31/2004 | EP1401377A2 Methods for treating cancer |
| 03/31/2004 | EP1401282A1 Stem cell differentiation |
| 03/31/2004 | EP1401271A2 Method and apparatus for reducing pathogens in a biological sample |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1401268A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 03/31/2004 | EP1270599B1 Salmon-origin chondroitin sulfate |
| 03/31/2004 | EP1235902A4 Olfactory ensheathing cells isolated from the lamina propria |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1011710A4 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0775005B1 Blood processing systems controlled by apparent hematocrit |
| 03/31/2004 | EP0746625B1 Targetable vector particles |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | CN1486194A Colorstrum-based composition |
| 03/31/2004 | CN1486189A Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
| 03/31/2004 | CN1485075A Lotion for treating hyperosteogeny |
| 03/31/2004 | CN1485057A Acne-treating composition |
| 03/31/2004 | CN1485052A aqualene composition with anti-fatigue and delaying ageing function |
| 03/31/2004 | CN1485051A Medication formulation for chronic bronchitis and bronchial asthma and preparation method |
| 03/31/2004 | CN1485050A Production method of medical healthcare beautifying product |
| 03/31/2004 | CN1484972A Anti-diarrhea yelk antibody feed additive for swine and injection formulation, and preparation method |
| 03/31/2004 | CN1143687C Plaster for treating cervical vertebra hyperplasia |
| 03/31/2004 | CN1143683C Exterior-applied black plaster for treating bone diseases and its preparing process |
| 03/30/2004 | US6713269 Cell culltures for use in detcetion, evaluation and treatment of bone disorders |
| 03/30/2004 | US6713252 Using adsorption carrier |
| 03/30/2004 | US6713246 Method of producing interleukin-1 receptor antagonist in a syringe filled with blood |
| 03/30/2004 | US6713245 Contacting a population of porcine neural cells with a hibernation medium to produce a cell suspension; maintaining the cell suspension at about 4 degrees c. to thereby store a population of neural cells suitable for transplantation |
| 03/30/2004 | US6713084 Promoting healing of a laser skin resurfacing wound, preserved sheet of allogeneic or xenogeneic cultured epithelial cells |
| 03/30/2004 | US6713079 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from l-arganine analog, dextran, heparin, cysteine and cystine |
| 03/30/2004 | US6713067 Which: (i) lacks a functional vhs gene, or a functional equivalent thereof; and (ii) comprises a functional ul43 gene, or a functional equivalent thereof such that dendritic cells are infected with said virus. |
| 03/30/2004 | US6713056 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 03/30/2004 | US6713054 Cellular immunotherapy treatment of patients afflicted with chronic fatigue syndrome |
| 03/30/2004 | US6713053 Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
| 03/30/2004 | US6712023 Culture of sessile marine animals |
| 03/30/2004 | CA2235471C Dna encoding a plasminogen activating protein |
| 03/30/2004 | CA2109065C Bioartificial endocrine device |
| 03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024902A1 A method of treating an autoimmune disease |
| 03/25/2004 | WO2004024900A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 03/25/2004 | WO2004024875A2 Mammalian megakaryocyte progenitor cell |
| 03/25/2004 | WO2004024865A2 Biocontrol for plants with bacillus subtilis, pseudomonas putida, and sporobolomyces roseus |
| 03/25/2004 | WO2004024198A1 Activator for forming platelet gel, platelet poor plasma gel or platelet rich plasma gel |
| 03/25/2004 | WO2004024174A1 Method and composition for regulating the activity of regulatory t cells |
| 03/25/2004 | WO2004024171A1 Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
| 03/25/2004 | WO2004024170A1 Method of treating biological tissue for transplantation by applying ultrahigh hydrostatic pressure |
| 03/25/2004 | WO2004024169A1 Composition comprising an abrasive agent for treating insect bites |
| 03/25/2004 | WO2004024129A1 Induced remission therapy |
| 03/25/2004 | WO2004011012A3 Stem cells for treating pancreatic damage |
| 03/25/2004 | WO2004006954A3 Transdermal botulinum toxin compositions |
| 03/25/2004 | WO2004000340A3 Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract |
| 03/25/2004 | WO2003106640A3 Cell targeting methods and compositions |
| 03/25/2004 | WO2003104441A3 Bacterial strain, compositions derived therefrom and methods of using same for treating beta-amyloid peptide-associated deseases |
| 03/25/2004 | WO2003095606A3 A t cell subpopulation regulating gut immunity |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003092894A3 Method and apparatus for isolating platelets from blood |
| 03/25/2004 | WO2003084468A3 Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof |
| 03/25/2004 | WO2003083064A3 Chimeric pancreas |
| 03/25/2004 | WO2003076591A3 Compositions and methods for generating an immune response |
| 03/25/2004 | WO2003045427A3 Pharmaceutical composition for inducing an immune response in a human or animal |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2002102993A3 Human secreted proteins |
| 03/25/2004 | WO2002092756A8 Insulin producing cells derived from human embryonic stem cells |
| 03/25/2004 | WO2002066044A3 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2001092470A3 Dna expression vectors and methods of use |
| 03/25/2004 | US20040059186 Insemination device |
| 03/25/2004 | US20040059142 Combining a crude arachidonic acid(ARA) a polyunsaturated fatty acids (PUFAs) containing oil with a crude DHA OR EPA(docosahexaenoic acid or eicosapentaenoic acid) containing oil, purifying to produce purified ARA, DHA or EPA |
| 03/25/2004 | US20040059089 Comprises receptor protein for controlling gene expression in transgenic cells; for diagnosis, prevention and treatment of heart, tumor and urogenital disorders |
| 03/25/2004 | US20040058887 Releasing drug, cosmetics to cells; flexible kinetics release patterns |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058866 Method for preparing tryptophan rich peptides |
| 03/25/2004 | US20040058444 Bioprosthetic heart valves |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058442 Oral progenitor cell culture for propagation and transplantion into oral cavity; restorative/regenerative dentistry |
| 03/25/2004 | US20040058412 Cell populations which co-express CD49c and CD90 |
| 03/25/2004 | US20040058392 Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition |